Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,544 | 202 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $501.28 | 32 | $0 (2024) |
| Novo Nordisk Inc | $419.37 | 25 | $0 (2024) |
| Lilly USA, LLC | $361.86 | 21 | $0 (2024) |
| Amgen Inc. | $222.44 | 14 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $216.55 | 9 | $0 (2024) |
| Insulet Corporation | $170.43 | 8 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $129.99 | 8 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $126.66 | 8 | $0 (2024) |
| GlaxoSmithKline, LLC. | $114.56 | 7 | $0 (2023) |
| Ferring Pharmaceuticals Inc. | $109.20 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $653.70 | 34 | Otsuka America Pharmaceutical, Inc. ($92.77) |
| 2023 | $1,134 | 64 | AbbVie Inc. ($242.60) |
| 2022 | $543.68 | 31 | ABBVIE INC. ($59.77) |
| 2021 | $1,074 | 64 | Novo Nordisk Inc ($163.27) |
| 2020 | $138.71 | 9 | Merck Sharp & Dohme Corporation ($43.43) |
All Payment Transactions
202 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Obesity | ||||||
| 11/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $15.19 | General |
| Category: Insulin Pump | ||||||
| 10/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Gastroenterology | ||||||
| 09/09/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Oncology | ||||||
| 08/28/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: NEUROSCIENCE | ||||||
| 06/07/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $26.00 | General |
| Category: Insulin Pump | ||||||
| 05/08/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Cardiology | ||||||
| 04/15/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Bone Health | ||||||
| 04/05/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $28.52 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/02/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: NEUROSCIENCE | ||||||
| 03/25/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Inflammation | ||||||
| 03/22/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: PSYCHIATRY | ||||||
| 03/21/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Biological | ||||||
| 03/14/2024 | Almatica Pharma LLC | TERIPARATIDE (Drug) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: OSTEOPOROSIS | ||||||
| 03/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: Obesity | ||||||
| 03/11/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: Diabetes | ||||||
| 03/05/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/05/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: VACCINE | ||||||
| 02/27/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $24.33 | General |
| 02/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/19/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Inflammation | ||||||
| 02/15/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $25.43 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 398 | 547 | $76,151 | $36,686 |
| 2022 | 7 | 218 | 287 | $41,134 | $21,906 |
| 2021 | 7 | 178 | 271 | $42,640 | $19,433 |
| 2020 | 2 | 29 | 30 | $6,084 | $3,001 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 107 | 202 | $36,582 | $16,573 | 45.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 63 | 63 | $10,190 | $7,527 | 73.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 60 | 72 | $8,890 | $4,116 | 46.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 12 | 12 | $5,016 | $3,088 | 61.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 26 | 26 | $3,790 | $1,791 | 47.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $4,242 | $1,050 | 24.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 29 | 29 | $986.00 | $837.23 | 84.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 12 | 14 | $1,703 | $543.76 | 31.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 39 | $1,560 | $409.11 | 26.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 14 | 14 | $476.00 | $375.31 | 78.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 14 | 23 | $1,748 | $218.96 | 12.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 15 | 17 | $408.00 | $117.60 | 28.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 17 | 20 | $560.00 | $39.60 | 7.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 76 | 134 | $22,914 | $11,314 | 49.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 42 | 42 | $6,594 | $5,151 | 78.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 33 | $3,762 | $1,897 | 50.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 22 | 22 | $2,882 | $1,508 | 52.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $3,406 | $1,193 | 35.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 24 | 24 | $816.00 | $652.08 | 79.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 12 | 19 | $760.00 | $190.59 | 25.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 48 | 130 | $22,230 | $12,121 | 54.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 43 | 43 | $11,266 | $2,322 | 20.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 14 | 14 | $2,198 | $1,759 | 80.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 26 | 34 | $3,876 | $1,691 | 43.6% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 17 | 17 | $1,360 | $1,105 | 81.3% |
About Jelisa Carroll
Jelisa Carroll is a Family Medicine healthcare provider based in Brunswick, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2017. The National Provider Identifier (NPI) number assigned to this provider is 1396271292.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jelisa Carroll has received a total of $3,544 in payments from pharmaceutical and medical device companies, with $653.70 received in 2024. These payments were reported across 202 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($3,544).
As a Medicare-enrolled provider, Carroll has provided services to 823 Medicare beneficiaries, totaling 1,135 services with total Medicare billing of $81,026. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Brunswick, GA
- Active Since 05/11/2017
- Last Updated 07/12/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1396271292
Products in Payments
- VRAYLAR (Drug) $321.54
- MOUNJARO (Drug) $217.57
- REXULTI (Drug) $216.55
- Omnipod (Device) $170.43
- EVENITY (Biological) $148.73
- Ozempic (Drug) $141.28
- UBRELVY (Drug) $140.99
- ENTRESTO (Drug) $129.99
- EUFLEXXA (Device) $109.20
- Wegovy (Drug) $101.17
- EMGALITY (Drug) $96.64
- NURTEC ODT (Drug) $76.90
- XARELTO (Drug) $70.63
- TRELEGY ELLIPTA (Drug) $66.26
- PREVNAR 20 (Biological) $63.59
- Rybelsus (Drug) $61.86
- Vascepa (Drug) $59.97
- FREESTYLE LIBRE 2 (Device) $59.53
- Otezla (Drug) $56.88
- VOQUEZNA (Drug) $51.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Brunswick
James Fleming, M.d, M.D
Family Medicine — Payments: $6,870
Michael Macdonald, Md, MD
Family Medicine — Payments: $5,525
Leonard Kinland, M.d, M.D
Family Medicine — Payments: $5,252
Dr. John Blumer, M.d, M.D
Family Medicine — Payments: $4,731
Mark Meacham, Md, MD
Family Medicine — Payments: $3,673
Kathleen Stern, M.d, M.D
Family Medicine — Payments: $2,909